FDA Doctor Calls GSK Avandia Trial Biased
A U.S. Food and Drug Administration doctor has blasted a GlaxoSmithKline PLC trial for its diabetes drug Avandia, which the company has held up as proof that the controversial blockbuster does...To view the full article, register now.
Already a subscriber? Click here to view full article